Amy Furlong is a seasoned executive in the biopharma and healthcare clinical technology sectors, currently serving as President of the Board of Directors at IDDI and as a Strategic Advisor at Studion. With a robust background as an Independent Executive Consultant since June 2021, and previous roles including Chief Operations Officer at YourEncore and various executive positions at ERT, Amy has demonstrated expertise in operations, M&A integration, and product line management. Amy’s leadership in establishing compliance and quality programs has significantly contributed to operational efficiencies and corporate growth. Educational qualifications include a B.S. in Biology and a Master of Science in Pharmaceutical Sciences with a focus on Regulatory Affairs from Temple University.
This person is not in the org chart
This person is not in any teams
IDDI - Biostatistics & Clinical Data Science Experts
IDDI is a therapy-focused expert clinical data services and high-level strategic consulting contract research organization committed to increasing efficiency and mitigating risks throughout the drug development process. For over 30 years, we have provided agile clinical trial services for pharmaceutical, biotechnology, and medical device/diagnostic companies to ensure their clinical data is ready for submission. With a deep expertise in advanced biostatistics and study design, we also offer regulatory, statistical and clinical consultancy, comprehensive data management services and integrated RTSM-EDC for the successful execution of your clinical development program even with complex settings. IDDI is Passion, Science, and Experience to ensure your data is ready for submission!